NFKB1 and cancer: Fortunately, however, AIMs showed anti-cancer effects in in vivo systems, by inhibiting NF-κB and its downstream molecules that are involved in cancer proliferation, invasion and metastasis, so it was possible to conclude that AIM also showed anti-cancer effects in vivo.